ArticleCancer immunology, immunotherapy : CII2004

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.

Hiroki Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.